Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2025-11-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Work Rules for the Board Secretary' of Northeast Pharmaceutical Group Co., Ltd. It details the qualifications, duties, appointment, and dismissal procedures of the company's board secretary. It is a governance-related internal regulation document rather than a financial report, announcement, or meeting material. There are no financial statements, earnings data, voting results, or regulatory filings. The content aligns with governance practices and internal company rules regarding board secretary responsibilities. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2807 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report publication notice.
2025-11-28 Chinese
总经理工作细则
Governance Information Classification · 95% confidence The document is titled as '东北制药集团股份有限公司 总经理工作细则' which translates to 'Northeast Pharmaceutical Group Co., Ltd. General Manager Work Rules'. It details the governance structure, roles, responsibilities, appointment procedures, and reporting duties of the company's general manager and senior management. It references company law and internal company articles but does not contain financial statements, audit results, or financial performance data. It is a governance-related document outlining internal management rules and procedures rather than a financial report or announcement. The document length is about 4604 characters, which is substantial and contains detailed governance content. Therefore, the most appropriate classification is Governance Information (CGR).
2025-11-28 Chinese
关于会计估计变更的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from a company regarding a change in accounting estimates related to depreciation of fixed assets. It includes details about the change, its effective date, reasons, and approvals by the board and audit committee. The document explicitly states that the change does not affect prior financial statements and does not require shareholder approval. The document length is short (1450 characters), and it is an announcement of an accounting policy change rather than a full financial report or audit report. It does not contain actual financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-11-28 Chinese
关于召开2025年第二次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2025 second extraordinary general meeting of shareholders for Dongbei Pharmaceutical Group Co., Ltd. It includes information about the meeting time, location, agenda items, voting procedures, and proxy forms. The content focuses on the announcement and procedural details for the shareholders' meeting rather than the results of the vote or the meeting itself. It does not contain financial statements, audit opinions, or earnings data. The document length is 4270 characters, which is relatively short and consistent with a meeting notice. Therefore, this document is best classified as a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-11-28 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Northeast Pharmaceutical Group Co., Ltd., covering company organization, shareholder rights, board structure, share issuance, shareholder meetings, and governance rules. It references laws and regulations, shareholder meeting procedures, board responsibilities, and internal governance. It is not a financial report, earnings release, or announcement but a comprehensive governance document outlining the company's internal rules and structure. Therefore, it fits the category of Governance Information (CGR). The document length and content confirm it is the actual governance document, not an announcement or summary.
2025-11-28 Chinese
董事会战略委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Strategic Committee Work Rules' of Northeast Pharmaceutical Group Co., Ltd. It details the structure, responsibilities, and procedures of the board's strategic committee. The content focuses on governance, committee composition, duties, meeting rules, and decision-making processes. There is no financial data, earnings information, or regulatory filing content. It is a governance-related document outlining internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length is 2070 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report publication.
2025-11-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.